Docket Number:12T-1030920
Inventor:Pang-Hsien Tu, Wen-Chuan Shen, Yu-May Lee, Yijuang Chern
IP Status:Know-how
Abstract:
Huntington’s disease (HD) is a neurodegenerative disease characterized by progressive cognitive, psychiatric and motor deficits which correlate with neuronal loss in the cortex and striatum. It is caused by an abnormal expansion of CAG repeat in the HTT gene encoding huntingtin (HTT). The monoclonal antibody was raised against isolated soluble as well as insoluble GFP-tagged HTTex1 with expanded polyglutamine (polyQ) stretch from cells and can detect exogenously expressed normal and mutant HTT protein in Neuro2a cells or mutant HTT transgenic protein in HD transgenic mice R6/2.
Fields of Application:
The antibody effectively detects HTT by ELISA, IHC and immunoblots.
Advantages when compared to the existing technologies:
Shorter hybridization time compared with EM48 monoclonal antibody.
Contact Person:Mei-Fang Lee / 886-2-2787-2503 / mflee@gate.sinica.edu.tw
